About this trial
This clinical trial compares the use of oral nicotine pouches to nicotine replacement therapy, consisting of nicotine patches and lozenges, to reduce cigarette use in smokers living in rural Appalachia. The lung and oral cancers that plague Appalachia are fueled by cigarette smoking. Oral nicotine pouches which contain nicotine but no tobacco leaf, present a new opportunity to reduce cancer risk among Appalachian adults who smoke. Oral nicotine pouches and nicotine replacement therapy may work well to reduce cigarette use for smokers in rural Appalachia.
Eligibility criteria
Qualifiers
Read and speak English
21 years or older
Smoke ≥ 5 cigarettes per day for the past year
Willing to use Oral Nicotine Pouches (ONP) or Nicotine Replacement Therapy (NRT)
Disqualifiers
Report currently using smoking cessation medications, NRT, or actively seeking treatment for smoking cessation
Use of ONPs in past 3 months
Use of Nicotine Replacement Therapies in past 3 months
Use of other tobacco products > 10 days/month
Trial design
Treatments tested in this trial
- Carbon Monoxide Measurement
- Nicotine Lozenge
- Oral Nicotine Pouch
- Nicotine Patch
- Survey Administration
- Check-in Phone Calls
Treatment groups
Sponsors and collaborators
Ohio State University Comprehensive Cancer Center
Lead sponsor
National Cancer Institute (NCI)
Collaborator